You have 9 free searches left this month | for more free features.

plerixafor

Showing 1 - 25 of 76

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Relapsed Adult ALL, Relapsed Adult AML Trial in Changchun (Plerixafor)

Active, not recruiting
  • Relapsed Adult ALL
  • Relapsed Adult AML
  • Plerixafor
  • Changchun, Jilin, China
    First Hospital of Jilin University
Nov 19, 2023

Sickle Cell Disease Trial in Memphis (Plerixafor)

Recruiting
  • Sickle Cell Disease
  • Plerixafor
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Jan 11, 2023

Multiple Myeloma Trial in Stanford (MGTA-145, Plerixafor)

Completed
  • Multiple Myeloma
  • Stanford, California
    Stanford University
Aug 17, 2022

Sickle Cell Disease Trial in Boston, Memphis (MGTA-145, Plerixafor)

Recruiting
  • Sickle Cell Disease
  • MGTA-145
  • Plerixafor
  • Bethesda, Maryland
  • +2 more
Nov 4, 2022

Sickle Cell Disease Trial in Duarte (Plerixafor)

Recruiting
  • Sickle Cell Disease
  • Plerixafor
  • Duarte, California
    City of Hope Medical Center
Feb 17, 2022

Sickle Cell Disease Trial in New York (Plerixafor)

Recruiting
  • Sickle Cell Disease
  • Plerixafor
  • New York, New York
  • +1 more
Mar 21, 2022

Fanconi Anemia Trial in Paris (G-CSF, Plerixafor)

Completed
  • Fanconi Anemia
  • Paris, France
    Hôpital necker-Enfants malades
Dec 20, 2021

Idiopathic CD4-Positive, T-Lymphocytopenia Trial run by the National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting
  • Idiopathic CD4-Positive
  • T-Lymphocytopenia
  • Filgrastim
  • Plerixafor
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 21, 2023

Asherman Syndrome, Atrophic Endometrium, Recurrent Implantation Failure Trial in Orange (Plerixafor)

Not yet recruiting
  • Asherman Syndrome
  • +2 more
  • Plerixafor
  • Orange, Connecticut
    Yale Fertility Center
Jul 13, 2022

Sickle Cell Anemia, Beta Thalassemia Trial run by the NHLBI (radiation, drug, biological)

Recruiting
  • Sickle Cell Anemia
  • Beta Thalassemia
  • TBI
  • +6 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 26, 2023

Poor Mobilizer (PM) in Multiple Myeloma (MM) Patients

Active, not recruiting
  • Multiple Myeloma
  • Plerixafor
  • Torino, Italy
    A.O.U. Città della Salute e della Scienza di Torino
Aug 17, 2021

T-cell Non-Hodgkin Lymphoma Trial in Boston (Cyclophosphamide, Doxorubicin, Vincristine)

Terminated
  • T-cell Non-Hodgkin Lymphoma
  • Boston, Massachusetts
  • +1 more
Jan 26, 2023

HIV, Hematologic Malignancies Trial run by the National Cancer Institute (NCI) (RIC, GVHD prophylaxis, allo HCT)

Not yet recruiting
  • HIV
  • Hematologic Malignancies
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 17, 2022

Myeloma Trial in Chicago (drug, procedure, device)

Active, not recruiting
  • Myeloma
  • Chicago, Illinois
    University of Chicago
Sep 14, 2021

Sickle Cell Disease Trial in United States (biological, drug, genetic)

Recruiting
  • Sickle Cell Disease
  • Plerixafor
  • +2 more
  • Oakland, California
  • +5 more
Sep 13, 2022

Stem Cell Transplantation, Leukemia Trial in Houston (Plerixafor, Filgrastim, Fludarabine)

Completed
  • Stem Cell Transplantation
  • Leukemia
  • Plerixafor
  • +5 more
  • Houston, Texas
    UT MD Anderson Cancer Center
Sep 22, 2020

Transplants and Implants Trial in Cincinnati (plerixafor, Bortezomib, plasmapheresis)

Unknown status
  • Transplants and Implants
  • plerixafor
  • +2 more
  • Cincinnati, Ohio
  • +1 more
Jun 29, 2020

Related Donors Donating PBSC to a Family Member, Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in United States

Completed
  • Related Donors Donating PBSC to a Family Member
  • +7 more
  • Plerixafor
  • Tampa, Florida
  • +11 more
Sep 3, 2020

Glioblastoma, Gliosarcoma Trial in Seattle (radiation, procedure, drug, biological, other)

Completed
  • Glioblastoma
  • Gliosarcoma
  • 3-Dimensional Conformal Radiation Therapy
  • +10 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Mar 4, 2022

Multiple Myeloma Trial in United States (Plerixafor, bortezomib, Dexamethasone)

Completed
  • Multiple Myeloma
  • Plerixafor
  • +2 more
  • Boston, Massachusetts
  • +4 more
May 19, 2020

Allogeneic Hematopoietic Cell Transplantation (HCT), Advanced Hematologic Malignancies, Acute Leukemia Trial in Stanford

Recruiting
  • Allogeneic Hematopoietic Cell Transplantation (HCT)
  • +5 more
  • Purified regulatory T-cells (Treg) plus CD34+ HSPC
  • +7 more
  • Stanford, California
    Stanford University
Oct 28, 2021

Sickle Cell Disease Trial run by the NHLBI (Plerixafor)

Completed
  • Sickle Cell Disease
  • Plerixafor
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Apr 13, 2020

Pancreas Cancer Trial in New York, Cambridge (Plerixafor)

Terminated
  • Pancreas Cancer
  • Plerixafor
  • New York, New York
  • +1 more
Feb 27, 2020

Diabetes, Wounds, Critical Limb Ischemia Trial in Padova (Plerixafor, Placebo)

Terminated
  • Diabetes
  • +2 more
  • Plerixafor
  • Placebo
  • Padova, Italy
    University Hospital of Padova
Dec 17, 2019

Fanconi Anemia Trial in Barcelona, Madrid (filgrastim, plerixafor)

Completed
  • Fanconi Anemia
  • Barcelona, Spain
  • +1 more
May 25, 2020